Issue 19

Here’s What to Expect from CPHI Milan

Why not sign up for our future email newsletters? Sign up here.

Included in this issue:

LEAD STORY

Bora Biologics Expands Through Acquisition and Partnership 

Bora Biologics has recently made a series of strategic moves aimed at better positioning itself to rapidly respond to industry’s evolving demands for capacity, integration, and policy developments - such as the U.S. BIOSECURE Act. As a result, the company is well positioned to capitalize on the growing demand for large-molecule CDMO services and opportunities presented by the growing demand for onshoring and friendshoring. 

Read more here.

FEATURED STORIES

Rising Tides and Biologics Growth for CDMOs

Read more here.

Serán Secures Funding for Commercial-Scale CDMO Services

Read more here.

Berry to Showcase Innovative Drug Delivery Solutions

Read more here.

Adare Collaborate with Laxxon to Add 3D Printing from Milan Facility

Read more here.

M&M to Address Packaging Trends and Solutions

Read more here.

Sanner Acquires Gilero to Expand Medical Device Offering

Read more here.

Steriline to Showcase Advanced Robotic Vial Filling and Capping Machine

Read more here.

Gelita to Showcase New Softgel and Collagen Solutions

Read more here.

Novo's Monlunabant Shows Side Effects in Phase 2 Trial

Read more here.

GLP-1 Discovery Award Recognition

Read more here.

FDA Inspection Backlog Delays Overseas Drug Approvals

Read more here.

Agilent Completes Acquisition of BIOVECTRA to Expand CDMO Capabilities

Read more here.

Phillips Medisize to Acquire Vectura, Expanding Inhalation Drug Delivery Capabilities

Read more here.